M. A. Bakitas, T. D. Tosteson, and Z. Li, Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial, J Clin Oncol, vol.33, pp.1438-1483, 2015.

, Loi n°99-447 Du 9 juin 1999 visant à garantir le droit à l'accès aux soins palliatifs. JORF n° 132 du 10 juin, 1999.

J. S. Temel, J. A. Greer, and A. Muzikansky, Early palliative care for patients with metastatic non-small-cell lung cancer, N Engl J Med, vol.363, pp.733-775, 2010.

, Pittsburgh: National Consensus Project, 2009. www. nationalc onse nsus proj ect. org

W. F. Pirl, J. A. Greer, and L. Traeger, Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care, J Clin Oncol, vol.30, pp.1310-1315, 2012.

L. E. Schnipper, T. J. Smith, and D. Raghavan, American Society of clinical oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology, J Clin Oncol, vol.30, pp.1715-1739, 2012.

T. Conroy, F. Desseigne, and M. Ychou, FOLFIRINOX improves survival in patients with metastatic pancreatic Cancer, N Engl J Med, vol.364, pp.1817-1842, 2011.

F. Lordick, Y. K. Kang, and H. C. Chung, Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial, Lancet Oncol, vol.14, pp.490-499, 2013.

D. Malka, P. Cervera, and S. Foulon, Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial, Lancet Oncol, vol.15, pp.819-847, 2014.

M. Ducreux, S. Cuhna, A. Caramella, and C. , Cancer of the pancreas: esmo Clinical Practice guidelines, Ann Oncol, vol.26, issue.5, pp.56-68, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01810223

J. W. Valle, I. Borbath, and S. A. Khan, Biliary cancer: esmo clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.27, issue.5, pp.28-37, 2016.

E. C. Smyth, M. Verheij, and W. Allum, Gastric Cancer: esmo clinical Practice guidelines, Ann Oncol, vol.27, issue.5, pp.38-49, 2016.

M. M. Oken, R. H. Creech, and D. C. Tormey, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, vol.5, pp.649-56, 1982.

K. Lan and D. L. Demets, Discrete Sequential Boundaries for clinical trials, Biometrika, vol.70, pp.659-63, 1983.

P. C. O'brien and T. R. Fleming, A multiple testing procedure for clinical trials, Biometrics, vol.35, pp.549-56, 1979.

P. Royston and M. K. Parmar, The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt, Stat Med, vol.30, pp.2409-2430, 2011.

, , 2017.